| Park Med Urgent Care Center | |
|
117 Gill St Alcoa TN 37701-2672 | |
| (865) 982-3409 | |
| Not Available |
| Full Name | Park Med Urgent Care Center |
|---|---|
| Speciality | Family Medicine |
| Location | 117 Gill St, Alcoa, Tennessee |
| Authorized Official Name and Position | David M Maloney (DIRECTOR/ SECRETARY) |
| Authorized Official Contact | 6156562750 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Park Med Urgent Care Center 216 Centerview Dr Ste 100 Brentwood TN 37027-3226 Ph: () - | Park Med Urgent Care Center 117 Gill St Alcoa TN 37701-2672 Ph: (865) 982-3409 |
| NPI Number | 1396777595 |
|---|---|
| Provider Enumeration Date | 07/07/2006 |
| Last Update Date | 04/10/2024 |
| Medicare PECOS PAC ID | 3375505134 |
|---|---|
| Medicare Enrollment ID | O20041103000465 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396777595 | NPI | - | NPPES |
| 3017295 | Other | TN | BLUECROSS/BLUESHIELD |
| Provider Name | Omar L Hamada |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1750358131 PECOS PAC ID: 7618881517 Enrollment ID: I20031204000442 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Paul Michael Carter |
|---|---|
| Provider Type | Practitioner - Allergy/immunology |
| Provider Identifiers | NPI Number: 1710972872 PECOS PAC ID: 2769389824 Enrollment ID: I20031217000041 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Timothy P Wilson |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1417984139 PECOS PAC ID: 7618954066 Enrollment ID: I20040702000448 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | John D Rooke |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1336176056 PECOS PAC ID: 2567413800 Enrollment ID: I20050203000920 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | David A Hancock |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1194753459 PECOS PAC ID: 1456397405 Enrollment ID: I20050630000236 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | George Vandenburg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497798565 PECOS PAC ID: 1850342437 Enrollment ID: I20070523000666 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Prayrana Chhabra Joseph |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1215953807 PECOS PAC ID: 2466520036 Enrollment ID: I20081226000114 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Maria Voutsina-kerny |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902210628 PECOS PAC ID: 4688896525 Enrollment ID: I20141110001818 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Andrew S Herda |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1215225891 PECOS PAC ID: 5395988364 Enrollment ID: I20150504002030 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Franklin Farmer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1881060168 PECOS PAC ID: 7416232913 Enrollment ID: I20170324002184 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Tyler Mark Hartman |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1902212657 PECOS PAC ID: 3577788124 Enrollment ID: I20170809003777 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Michael David Corvini |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396770699 PECOS PAC ID: 0446256150 Enrollment ID: I20171122000068 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Christopher W Spruell |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1922462928 PECOS PAC ID: 4880937580 Enrollment ID: I20210701001538 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Daniela Caballero Varona |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1104221902 PECOS PAC ID: 5092040089 Enrollment ID: I20210726001100 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Joseph Thompson Crane |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1760420236 PECOS PAC ID: 2264339498 Enrollment ID: I20210817001534 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Joseph Linyun Chow |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1235125550 PECOS PAC ID: 2961599386 Enrollment ID: I20210818002541 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Mark P Plexousakis |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1861644171 PECOS PAC ID: 7618030883 Enrollment ID: I20210914000683 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
| Provider Name | Jenni Canestrari |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851025266 PECOS PAC ID: 6305218728 Enrollment ID: I20230214000139 |
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
News Archive
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.
Routledge is pleased to announce the publication of Volume 60, Issue 7, 2012 - the Tobacco Issue - from Journal of American College Health (JACH).
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
› Verified 1 days ago
Ut Health And Wellness Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 281 Cusick Rd, Alcoa, TN 37701 Phone: 865-980-9721 Fax: 865-970-2089 | |
U.t. Family Physicians Alcoa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 281 Cusick Rd, Alcoa, TN 37701 Phone: 865-970-0025 Fax: 865-970-2089 | |
Alcoa Senior Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2445 Calderwood St., Suite C2, Alcoa, TN 37701 Phone: 865-681-2681 | |
Winbigler Medical, Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1205 Lodge St, Alcoa, TN 37701 Phone: 865-982-4631 Fax: 865-380-2240 | |
U.t. Family Physicians Alcoa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 281 Cusick Rd, Alcoa, TN 37701 Phone: 865-970-3737 Fax: 865-970-2089 | |
Tennessee Vein Center, Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 203 Corporate Place, Alcoa, TN 37701 Phone: 865-365-8346 |